A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells
Authors:
Open Access
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 312 (2) , 158-167
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M TransitionJournal of Biological Chemistry, 2010
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic CellsMolecular Pharmacology, 2009
- Characterization of Celastrol to Inhibit Hsp90 and Cdc37 InteractionJournal of Biological Chemistry, 2009
- Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cellsNeuro-Oncology, 2009
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic MelanomaClinical Cancer Research, 2008
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and MisidentificationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1Proceedings of the National Academy of Sciences, 2007
- Mutations of the BRAF gene in human cancerNature, 2002